Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nicardipine on blood flow of deep inferior epigastric artery in breast reconstruction
KCT0005015Phase 4Withdrawn
- Sponsor
- Asan Medical Center
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicardipine in breast cancer, sponsored by Asan Medical Center. Planned start Jun 2020; status: withdrawn.
02
Drugs
nicardipine
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0005015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005015.